H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 10.9% of adults in Coral Springs have diagnosed diabetes — 1.1 points below the U.S. 12% figure. Census population 134,394. Florida Medicare wound biologics: First Coast Service Options (JN). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Coral Springs clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Coral Springs storefront.
Biologic Therapy for Osteoarthritis in Coral Springs, FL for clinics & physicians. Biologic therapy option… Compliance support & pricing — contact Hawk Medical.
Adult obesity in Coral Springs is 28.7% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. CDC PLACES (2023, crude) estimates 10.9% of adults in Coral Springs have diagnosed diabetes — 1.1 points below the U.S. 12% figure. Florida includes CDC Diabetes Belt counties, so DFU planning belongs in the annual budget. Hawk Medical is the distributor for osteoarthritis biologic therapy, not a walk-in clinic.
National Biologic Therapy for Osteoarthritis notes (how the product actually works)CDC PLACES (2023, crude) estimates 10.9% of adults in Coral Springs have diagnosed diabetes — 1.1 points below the U.S. 12% figure. Adult obesity in Coral Springs is 28.7% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. Adult arthritis here is 20.8% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Payer geography: JN / First Coast Service Options, sibling states no other states. Florida Department of Health is the public-health home. We will not mash those grains into a fake “demand score.”
If you already buy osteoarthritis biologic therapy elsewhere, use this page as a check: homologous-use language, current First Coast Service Options article IDs, and PLACES 10.9% diabetes as the epidemiologic floor. If that is how you already practice, the catalog will fit.
CDC PLACES (2023, crude prevalence) estimates 10.9% of adults — 1.1 points below the U.S. 12% figure. Obesity is 28.7%; arthritis is 20.8%. That is place-level BRFSS modeling, not a clinic census and not a Coral Springs trial.
CDC estimates 12% of the U.S. population has diabetes (40.1 million people, 2023). America's Health Rankings (BRFSS 2024) shows state adult rates from Colorado 8.4% to West Virginia 18.4%. We do not publish a made-up city diabetes count. Use national/state published rates plus your panel.
Florida is in CMS MAC JN, administered by First Coast Service Options. CTP and skin-substitute coverage is written at the MAC level. Confirm the current LCD/article before you set utilization — we help practices map product to those rules; we do not override them.
We do not publish a consumer directory of every account. Patients should ask their current specialist whether the practice offers biologic therapy for osteoarthritis and which products they use.
If you operate in Florida and another MAC state, say it on the first call. JN will not port 1:1. We would rather split utilization than watch a sister clinic copy Coral Springs tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Coral Springs, FL.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Coral Springs is JN geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Coral Springs — 1.1 points below the U.S. 12% figure. Planning input, not an outcomes claim.
Florida Part B wound biologics follow this contractor (siblings: no other states). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Coral Springs. Useful for joint-program math; still needs a diagnosis and privileging.
No Coral Springs storefront. Joe Bradley is an active practice owner. osteoarthritis biologic therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.